SightfileU.S. market data from official filings

TRAVERE THERAPEUTICS INC (TVTX)

Name: TRAVERE THERAPEUTICS INC (TVTX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001438533 · EDGAR filings · Updated 2026-07-09

TRAVERE THERAPEUTICS INC (TVTX) has reported institutional ownership of 109.0%, with 261 institutional managers holding positions valued at $3.01B per the latest 13F reporting period.

Institutional ownership

109.0%

Institutional managers

261

Reported 13F value

$3.01B

Insider activity

88 trans.

−$21.7M net selling

Latest updates

2026-07-09 — Current report (8-K) filed
2026-06-22 — Insider transaction reported (Form 4)
2026-06-17 — Employee-plan registration (S-8) filed
2026-06-16 — Insider transaction reported (Form 4)
2026-06-16 — Insider transaction reported (Form 4)
2026-06-16 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TRAVERE THERAPEUTICS INC has 261 institutional holders and institutional ownership of 109.0%.

Insider activity

Insiders reported 88 transactions (0 buys, 46 sells) across 16 reporting insiders, with a net reported value of −$21.7M.

Related companies

ARCUTIS BIOTHERAPEUTICS INC (ARQT) · ACADIA HEALTHCARE COMPANY IN (ACHC) · HIMS & HERS HEALTH INC (HIMS) · SUPERNUS PHARMACEUTICALS (SUPN) · VERACYTE INC (VCYT) · DENALI THERAPEUTICS INC (DNLI)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.